aMMP-8 Oral Fluid PoC Test in Relation to Oral and Systemic Diseases

• Egile Nagusiak: Timo Sorsa (Egilea), Solomon Olusegun Nwhator (Egilea), Dimitra Sakellari (Egilea), Andreas Grigoriadis (Egilea), Kehinde Adesola Umeizudike (Egilea), Ella Brandt (Egilea), Mutlu Keskin (Egilea), Taina Tervahartiala (Egilea), Pirjo Pärnänen (Egilea), Shipra Gupta (Egilea), Ritin Mohindra (Egilea), Nagihan Bostanci (Egilea), Nurcan Buduneli (Egilea), Ismo Tapani Räisänen (Egilea)
• Formatua: Liburua
• Argitaratua: Frontiers Media S.A., 2022-06-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

The manuscript uses the previously published literature and highlights the benefits of active-matrix metalloproteinase (aMMP)-8 chairside/point-of-care (PoC) diagnostic tools as adjunctive measures in oral and systemic diseases. Previous studies suggest that as a biomarker, aMMP-8 is more precise th...